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ABSTRACT 
International Journal of Exercise Science 12(3): 1023-1033, 2019. Although cognitive dysfunction is a 
common occurrence among breast cancer survivors, there is no widely recognized intervention for this 
debilitating condition. The purpose of this study was to determine whether floor/step aerobics (FSA) and/or 
treadmill walking (TMW) interventions can improve outcomes when compared to standard care (STC). Recent 
breast cancer survivors participated in 12 weeks of FSA (n=8), TMW (n=7), or STC (n=10) with pre/post 
assessments of cognition and fitness. Interaction effects between group and time were assessed with repeated 
measures ANOVA. Throughout the extent of cognitive and fitness assessments, there were found to be no 
statistically significant interactions between group and time. Because of the small sample size, these results 
should not be taken to mean that exercise cannot improve cognition in recent breast cancer survivors, but this 
study should be used as a baseline for designing similar studies with a longer intervention, more intense exercise 
program, or another alteration that might increase effectiveness of the intervention. More research is needed in 
this area, but until more specific study results are available, healthcare providers should continue to encourage 
breast cancer survivors to regularly participate in aerobic exercise to maintain physical function. 
 




An estimated 65% of breast cancer survivors suffer from dysfunction in a variety of cognitive 
domains (23), as described by the term “cancer-induced cognitive dysfunction” (CICD). 
Although cognition improves over time in many women, researchers have demonstrated that 
some breast cancer survivors who are 20 years post-treatment still score lower on 
neuropsychological assessments of verbal learning, executive function, and psychomotor 
function than do their age-matched counterparts (12). Other cognitive domains that are 
commonly hindered in this population include memory, processing speed, and attention. In 
general terms, breast cancer survivors often describe their symptoms as a change in memory, 
fogginess in the brain, difficulty focusing, decreased ability to follow directions, and trouble 
with multitasking (16). Because of their effect on daily tasks, these symptoms are likely to 
reduce quality of life in breast cancer survivors. 
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In accordance with the International Cognition and Cancer Task Force (ICCTF) guidelines (24), 
some researchers report the percentage of their participants who experienced objective 
cognitive decline from pre-treatment to post-treatment, rather than only reporting statistical 
data. By using the Mini-Mental State Exam to determine cognitive ability, Biglia and 
colleagues found that the number of breast cancer survivors (n = 40) who scored below the 
mean increased from 19.5% before treatment to 30.8% immediately post-treatment (4), which 
indicates that treatment for breast cancer decreases basic cognitive functions in a subset of 
survivors. Debess and colleagues found that 15.4% of their 120 breast cancer survivor 
participants demonstrated cognitive decline on at least two tests (5), which was considered to 
be a clinically significant decline. Vearncombe and colleagues reported that 16.9% of their 136 
breast cancer survivor participants had significant cognitive decline post-chemotherapy (21). 
Stewart and colleagues found that 31% of their 61 patients who were treated with 
chemotherapy showed reliable cognitive decline, while only 5% showed reliable improvement 
(20). These studies show that one sixth to one third of breast cancer survivors appear to suffer 
from clinically significant cognitive decline. However, since there are more than 3.5 million 
breast cancer survivors alive today (1), it could be extrapolated that ½ million to 1 million 
women in the United States alone have previously, or are currently, suffering from CICD. 
 
While it seems that treatment for breast cancer does not adversely impact cognition in all 
breast cancer survivors, there is enough evidence that it can significantly negatively impact 
many cognitive domains in a large number of women. Based on this evidence, it is important 
to consider whether interventions could reduce CICD to improve quality of life in those breast 
cancer survivors who are affected by this disorder.  
 
Chemotherapy-induced cognitive dysfunction can be reduced in rats by regular participation 
in physical activity. In a study by Fardell and colleagues, healthy adult rats were treated with a 
chemotherapy regimen that is known to cause cognitive dysfunction (8). Their control group 
remained sedentary while the intervention group was provided with access to a running 
wheel for four weeks. After this time, the physically active rats scored significantly higher than 
their sedentary counterparts on spatial reference memory and novel object recognition tests (p 
< .05). These results provide support for conducting a similar study with humans to determine 
if aerobic exercise is an effective intervention for reducing CICD. However, a recent Cochrane 
review reported that there is a substantial lack of conclusive data from well-designed, 
adequately sized studies regarding the impact of aerobic exercise on cognitive function in 
breast cancer survivors (9). 
 
In another study, 41 breast cancer survivors completed 12 weeks of cognitive training or a 
wait-list control period (11). Those in the intervention group had significantly improved post-
intervention scores in the Wisconsin Card Sorting Test (p = .008), letter fluency (p = .003), and 
the symbol search test (p = .009), demonstrating the effectiveness of cognitive training in this 
population. A cognitively challenging exercise intervention could potentially function 
similarly to a cognitive training program, enhancing cognition while also increasing 
cardiorespiratory fitness. 
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The aforementioned studies demonstrate that aerobic exercise and cognitive training both 
have the potential to improve cognitive function in breast cancer survivors. However, 
published research does not indicate whether there are additional benefits from combining 
these interventions. 
 
The primary purpose of this study was to determine whether aerobic exercise improves 
cognition in recent breast cancer survivors compared to a sedentary lifestyle or standard care 
(STC), and to identify whether floor/step aerobics (FSA) improves cognition more than does 
treadmill walking (TMW). FSA involves following frequently changing upper and lower body 
movement patterns from verbal cues by a group exercise leader, which adds a cognitive 
stimulus to the exercise program when compared to treadmill walking monotonously in a 
straight line. The secondary purpose of this study was to compare effects of FSA, TMW, and 
STC on cardiorespiratory fitness among breast cancer survivors to ensure that fitness benefits 





Participants were female, with a mean age of 60 years old, who reported being sedentary at 
enrollment. Study inclusion criteria required that they be within 3 months following 
completion of primary treatment for breast cancer. Ongoing treatments, such as tamoxifen and 
Herceptin, were allowed. Exclusion criteria included current pregnancy, participation in a 
concurrent exercise program, reconstructive surgery or surgery rehabilitation during the 
study, inability to obtain medical clearance, and inability to speak English fluently. The study 
design was approved by the Institutional Review Board at Washington State University (WSU) 
before recruitment began.  
 
Effect sizes are not readily available for exercise interventions on cognition among recent 
breast cancer survivors. Among adults, in general, the effect size of exercise on cognitive 
function is approximately 0.30 (3). Therefore, a power analysis demonstrated that 30 women 
were needed for this study, with 10 assigned to each group, in order to distinguish interaction 
effects. Within the allotted time frame, 25 women gave informed consent to participate and 
completed the study. Assessed subject characteristics did not differ significantly between 
groups at baseline (see Table 1). 
 
Table 1. Participant demographics. Shown as mean ± standard deviation. 
 FSA (n=8) TMW (n=7) STC (n=10) p-value 
Age 60.38 ± 10.07 58.71 ± 6.99 60.82 ± 11.54 0.908 
Education 15.38 ± 1.19 14.86 ± 2.55 14.40 ± 3.66 0.275 
Resting Heart Rate 71.67 ± 12.35 68.14 ± 7.47 72.15 ± 9.37 0.680 
Systolic Blood Pressure 122.67 ± 15.13 111.14 ± 11.13 125.54 ± 17.01 0.144 
Body Mass Index 31.24 ± 8.19 29.89 ± 7.15 29.23 ± 6.32 0.809 
Percent Body Fat 40.00 ± 6.17 39.77 ± 5.82 39.67 ± 7.09 0.993 
Timed Up & Go 8.28 ± 1.54 8.88 ± 1.05 9.17 ± 1.88 0.485 
Perceived Stress Scale 14.56 ± 7.54 11.29 ± 6.07 14.38 ± 5.68 0.528 
FSA: Floor/step aerobics, TMW: Treadmill walking, STC: Standard care. 
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Protocol 
All participants who met inclusion and exclusion criteria were enrolled into the study in one of 
three groups: FSA, TMW, or STC. They were assigned to a group based on the class time that 
they selected. To reduce the risk of home-based exercise as a confounding variable, all 
participants were asked to maintain their normal level of physical activity, except for attending 
designated exercise classes at the study site. Participants were asked to complete and return an 
exercise log to confirm their offsite physical activity. 
 
Women in the STC group were instructed to remain sedentary throughout the study, but were 
invited to attend 12 weeks of free exercise classes following post-testing as an incentive to 
submit exercise logs and complete post-testing. TMW and FSA participants attended exercise 
classes for 12 weeks at WSU’s Health Sciences Campus. The exercise prescription (frequency, 
intensity, time, and type) was based on the American College of Sports Medicine 
recommendations for this population (2): 30-50 minutes, three to five days per week of 
moderately intense aerobic exercise that uses large muscle groups. 
 
Frequency: Breast cancer survivors attended classes each Monday, Wednesday, and Thursday. 
Participants were allowed to miss three exercise classes; additional missed class days were 
required to be rescheduled. Intensity: All classes were held at a moderate intensity, which was 
monitored throughout class using heart rate (HR) and Borg’s ratings of perceived exertion 
(RPE) scale (7) in which exertion is rated between 6 and 20. Moderate intensity is classified as 
an RPE of 12-13 or HR of 40%-<60% of heart rate reserve (2). If exercising HR or RPE were not 
in the desired range at any checkpoint, participants were assisted with making modifications 
to intensity. Time: Exercise classes were 50 minutes long to allow participants to utilize the free 
one-hour parking on campus. By scheduling three classes per week, this duration also met the 
minimum national recommendations for weekly physical activity volume (2). Type: 
Participants were assigned to FSA or TMW classes for the duration of the study. The first half 
of each FSA class focused on step aerobics, and the second half of each class focused on floor 
aerobics. A single instructor designed and taught all classes using a standard 32-count design. 
In this format, movements are organized into 32-count blocks that are gradually learned 
throughout the session and then repeated until the class can perform them without any 
instructor cues. TMW classes began with a slower walk at an incline and concluded with a 
rapid walk with no incline, mimicking the speed and grade changes in the FSA classes. 
Treadmill speeds varied between individuals, but were set at a level that kept heart rates 
within the goal range. 
 
Data was collected during a separate testing appointment the week prior to and the week 
following the 12-week intervention, on non-exercise days, to reduce risk of a false positive 
cognitive improvement from acute exercise. To prepare for test days, participants were 
instructed to maintain their normal activities and intake, and to avoid products containing 
alcohol, caffeine, or tobacco. Assessments were conducted at a standard room temperature and 
humidity. A thorough explanation of test procedures was given prior to each test. Where 
standard protocols indicate, a demonstration or practice test were also given. 
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Cognition was assessed using a battery of traditional cognitive assessments to test all primary 
cognitive domains. The Trail Making Test-A (TMT-A) and Trail Making Test-B (TMT-B) (14) 
involve participants connecting numbered dots as quickly as possible, and rapidly alternating 
between numbered and lettered dots, respectively. TMT-A is an assessment of attention and 
processing speed; TMT-B assesses executive function. The Controlled Oral Word Association 
Tests (COWAT) (including FAS, category, and switching trials) (14) require participants to 
name as many words as possible, within certain criteria, in one minute. These assessments 
show verbal fluency. Design Fluency (DF) tests involve participants drawing a variety of 
shapes by connecting dots, also within one minute. Condition 1 involves connecting black 
dots, Condition 2 involves connecting white dots, and Condition 3 involves alternating 
between black and white dots. Conditions 1 and 2 assess attention and processing speed, while 
Condition 3 assesses executive function. The Grooved Pegboard Test (GPT) requires 
participants to place odd shaped pegs into a pegboard as quickly as possible, which shows 
psychomotor function. This was selected as a control test; results should not change with an 
exercise intervention. In order to determine cardiorespiratory fitness for exercise prescription, 
as well as to assess improvement following the intervention, fitness was estimated using the 
Ebbeling Submaximal Single-Stage Treadmill Walking Test (15, 22). In this test, participants 
walk on a treadmill at a self-selected speed and a 5% grade for four minutes, at which point 
exercising heart rate is assessed. Maximal VO2 was predicting using the standard Ebbeling 
equation, which uses age, gender, walking speed, and exercising heart rate as variables. Based 
on previous experience (13) treadmill speed was held constant during pre- and post-testing, 
leaving exercising HR as the only test variable between tests. 
 
Statistical Analysis 
Repeated measures analysis of variance (SPSS 23) indicated whether there was an interaction 
between group and time. Assessments were considered statistically significant if the 





Trail Making Tests: The statistical interaction between group and time for the TMT-A test was 
not significant (FSA: 26.00±6.17, 22.11±7.28; TMW: 25.08±9.36, 22.05±4.50; STC: 27.13±7.72, 
26.21±9.18; p = .637). Results are shown in Figure 1. The TMT-B also showed no interaction 
between group and time (FSA: 62.58±8.95, 51.77±15.46; TMW: 58.77±24.32, 57.79±22.70; STC: 
57.36±16.34, 48.54±16.51; p = .292). 
 
Verbal Fluency: There was no significant interaction of exercise group over time on verbal 
fluency scores when measured with the FAS test (FSA: 11.75±3.62, 13.69±3.51, TMW: 
13.57±4.50, 14.14±3.93, STC: 11.57±2.23, 10.86±4.02; p = .296), as shown in Figure 2, with the 
“category” trials (FSA: 44.00±11.77, 48.63±11.56; TMW: 42.00±12.65, 45.57±11.69; STC: 
36.20±7.24, 37.80±10.02; p = .662), or with the “switching” trial (FSA: 15.13±2.42, 14.00±2.39; 
TMW: 15.00±3.27, 16.43±3.21; STC: 13.10±2.56, 13.70±4.50; p = .369). 
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Figure 1. Effect of exercise modality over time on attention and processing speed during the TMT-A.  
 
 
Figure 2. Effect of exercise modality over time on verbal fluency. 
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Design Fluency: When assessing results from the DF test, it is standard to add scaled scores 
from Condition 1 and Condition 2, and then scale that sum. Using this procedure, the 
interaction between group and time on DF results was not statistically significant (FSA: 
12.75±3.69, 14.25±2.25; TMW: 11.71±2.63, 14.29±3.86; STC: 11.67±3.43, 12.00±2.74; p = .261). It is 
standard to also scale the sum of scaled scores from all three conditions. Results from this 
calculation were also insignificant (FSA: 12.63±3.70, 14.13±2.53; TMW: 12.00±2.52, 13.43±3.74; 
STC: 12.11±3.33, 12.67±3.32; p = .624). This is shown in Figure 3. 
 
 
Figure 3. Effect of exercise modality over time on design fluency. 
 
Grooved Pegboard: There was very little change in scores, and no interaction between group 
and time on the speed of test completion for the dominant hand (FSA: 77.07±13.29, 77.58±9.94; 
TMW: 62.88±8.05, 61.10±9.78; STC: 73.61±15.60, 70.02±11.51; p = .602) or the non-dominant 
hand (FSA: 76.02±9.36, 78.26±12.52; TMW: 78.72±7.01, 78.90±16.03; STC: 76.34±17.15, 
79.79±20.39; p = .863), indicating that exercise modality has little to no impact on psychomotor 
function. 
 
Fitness: Exercising heart rate decreased slightly following participation in the FSA and TMW 
interventions, whereas 12-weeks of STC resulted in an increased exercising heart rate. 
However, this did not result in a significant interaction between group and time (FSA: 
113.94±20.76, 108.25±22.94; TMW: 113.33±9.84, 102.58±10.81; STC: 105.36±12.84, 109.21±14.65; p 
= .101), indicating that intervention group assignment did not have a statistically significant 
effect on exercising heart rate, but demonstrating a potentially clinically important 
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improvement in cardiorespiratory fitness with either type of exercise. The percent of change in 
these results is shown in Figure 4 (p = .093).  
 
 




There was a significant interaction between group and time on TMT-A results (p = .011) in our 
similarly designed previous study of healthy women (13), indicating that FSA can be more 
effective than TMW at improving attention and processing speed in healthy women. Among 
breast cancer survivors, both FSA and TMW improved TMT-A results to a slightly greater, 
though not significant extent, compared to STC. It is possible that the small sample size 
prevented significant findings. It is also possible that the intervention was not rigorous enough 
to result in significant improvements.  
 
Researchers have shown that verbal fluency can be diminished in breast cancer survivors 
following treatment (10, 18). Our intervention did not result in significant improvements in 
verbal fluency using COWAT assessments. While exercise was expected to improve brain 
function, it is possible that physical movement does not improve verbal abilities. 
 
It was expected that executive function would increase to the greatest extent in FSA 
participants due to the nature of this modality, which requires multi-tasking processes in the 
brain. However, there was no indication of improvement in any group on the TMT-B or 
switching trial of verbal fluency, which were the two assessments of executive function. This 
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indicates that 12 weeks of structured aerobic exercise might not be sufficient to significantly 
improve executive function in recent breast cancer survivors. Rehabilitating executive function 
might also require more complex cognitive tasks than can be provided from an exercise 
modality. Interestingly, however, Ehlers et al. recently reported that breast cancer survivors 
who were more physically active, as measured by minutes of moderate-to-vigorous activity 
per day, had higher executive function than those who were less active, indicating that an 
active lifestyle might be as important as a structured exercise program (6).  
 
Similar to executive function, the interventions did not appear to have any impact on 
assessments of psychomotor function. Since psychomotor function was not directly challenged 
during the interventions, this was expected. 
 
Both exercise intervention groups had a decreased average exercising heart rate, with intensity 
held constant, during post-testing as compared to pre-testing. While this change was not 
statistically significant, it could be clinically significant if it was correlated with improvements 
in cardiorespiratory fitness. A decreased exercising heart rate with aerobic training is 
consistent with the literature (17) and demonstrates that the women assigned to FSA did not 
significantly reduce their fitness benefits, compared to those using a treadmill, by adding 
multi-directional, cognitively stimulating movements.  
 
The greatest limitation to this study was that it took more than 2 years to enroll 25 recent 
breast cancer survivors who completed the intervention and post-testing. Due to the extreme 
difficulty in recruitment, it was recommended that the study be closed before the target 
sample size of 30 was obtained, which increases the risk of type II errors. Directly correlated 
with the inadequate sample size was the inability to fully randomize participants. In an effort 
to get enough women who could participate in the study, consideration was given to class 
time preference, but not modality preference, when determining group assignment. Even so, 
classes did not have the recommended number of eight women for group dynamics (19).  
 
Future studies should focus on determining an exercise intervention to improve each domain 
of cognitive function among breast cancer survivors. Manipulation of intensity, duration, and 
frequency of each session could result in greater cognitive effects than were shown in this 
study. Strategies addressing muscular strength, endurance, and flexibility in a well-controlled 
cognitive intervention are also warranted. Additionally, research with cancer survivors should 
be conducted in collaboration with local oncologists who can refer all eligible patients and 
encourage participation. Finally, screening for subjective or objective cognitive dysfunction 
prior to enrollment would allow for greater benefits to be seen from an intervention. 
 
Although results were inconclusive, this study still provides some of the most specific 
information available regarding aerobic exercise modality for cognitive improvement among 
recent breast cancer survivors. In conjunction with previous research demonstrating the health 
benefits of exercise for cancer survivors and past studies showing cognitive improvement with 
exercise, this study demonstrates the need for more research in this area. 
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Participation in aerobic exercise has long been encouraged for health promotion and chronic 
disease prevention. It has previously been shown to be a safe and effective means for cancer 
survivors to reduce various cancer-related side effects. Until new studies provide further 
evidence, healthcare providers should encourage recent breast cancer survivors who suffer 





1. American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2016-2017. Atlanta: American 
Cancer Society, 2016. 
 
2. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia, 
PA: Wolters Kluwer Health; Lippincott Williams & Wilkins, 2018. 
 
3. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, and Vanhees L. Physical activity and enhanced fitness 
to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 
CD005381, 2008. 
 
4. Biglia N, Bounous VE, Malabaila A, Palmisano D, Torta DM, D'Alonzo M, Sismondi P, Torta R. Objective and 
self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur 
J Cancer Care (Engl) 21: 485-492, 2012. 
 
5. Debess J, Riis JO, Engebjerg MC, Ewertz M. Cognitive function after adjuvant treatment for early breast cancer: 
a population-based longitudinal study. Breast Cancer Res Treat 121: 91-100, 2010. 
 
6. Ehlers DK, Aguiñaga S, Cosman J, Severson J, Kramer AF, McAuley E. The effects of physical activity and 
fatigue on cognitive performance in breast cancer survivors. Breast Cancer Res Treat 165: 699-707, 2017. 
 
7. Eston RG, Williams JG. Reliability of ratings of perceived effort regulation of exercise intensity. Br J Sports Med 
22: 153-155, 1988. 
 
8. Fardell JE, Vardy J, Shah JD, Johnston IN. Cognitive impairments caused by oxaliplatin and 5-fluorouracil 
chemotherapy are ameliorated by physical activity. Psychopharmacol 6: 6, 2011. 
 
9. Furmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. 
Cochrane Database Syst Rev 9: CD005001, 2016. 
 
10. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, Munzel K. Cognitive function during 
neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109: 
1905-1913, 2007. 
 
11. Kesler S, Hadi Hosseini SM, Heckler C, Janelsins M, Palesh O, Mustian K, Morrow G. Cognitive training for 
improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer 13: 299-306, 
2013. 
 
12. Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB. Neuropsychological 
performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30: 1080-
1086, 2012. 
 
Int J Exerc Sci 12(3): 1023-1033, 2019 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
1033 
13. Larsen J, Cassel C-L, Knuth J. A Quasi-experiment of exercise modality effects on cognition and fitness in 
healthy women. J Sports Sci 4: 333-340, 2016. 
 
14. Lezak M. Neuropsychological Assessment. New York: Oxford University Press, 1983. 
 
15. Mitros M, Gabriel KP, Ainsworth B, Lee C, Herrmann S, Campbell K, Swan P. Comprehensive evaluation of a 
single-stage submaximal treadmill walking protocol in healthy, middle-aged women. Eur J Appl Physiol 111: 47-
56, 2011. 
 
16. Myers JS. Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum 39: 
E31-40, 2012. 
 
17. Pinto BM, Clark MM, Maruyama NC, Feder SI. Psychological and fitness changes associated with exercise 
participation among women with breast cancer. Psychooncol 12: 118-126, 2003. 
 
18. Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: results from a 
longitudinal study. Breast Cancer Res Treat 116: 113-123, 2009. 
 
19. Sandel SL, Judge JO, Landry N, Faria L, Ouellette R, Majczak M. Dance and movement program improves 
quality-of-life measures in breast cancer survivors. Cancer Nurs 28: 301-309, 2005. 
 
20. Stewart A, Collins B, Mackenzie J, Tomiak E, Verma S, Bielajew C. The cognitive effects of adjuvant 
chemotherapy in early stage breast cancer: a prospective study. Psychooncol 17: 122-130, 2008. 
 
21. Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G. Predictors of cognitive decline after 
chemotherapy in breast cancer patients. J Int Neuropsychol Soc 15: 951-962, 2009. 
 
22. Waddoups L, Wagner D, Fallon J, Heath E. Validation of a single-stage submaximal treadmill walking test. J 
Sports Sci 26: 491-497, 2008. 
 
23. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with 
chemotherapy in women with breast cancer. Cancer 116: 3348-3356., 2010. 
 
24. Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to 
harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12: 703-708, 2011. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
